Skip to main content
. Author manuscript; available in PMC: 2018 Dec 19.
Published in final edited form as: Future Oncol. 2010 Dec;6(12):1897–1913. doi: 10.2217/fon.10.149

Table 2.

Pharmacogenetic variation of SRD5A2 variants.

Substitution Finasteride (Ki nM)
WT 60 (52–72)
Single-point variant
P30L (rs61748121) 420
P48R (rs61748122) 22
F194L (rs61748126) 7
R227Q (rs9332964) 260
F234L (rs9332966) 200
Compound heterozygotes
V89L–A49T 150
V89L–T187M 89
V89L–F234L 154
Haplotypes (i.e., double mutants)
V89L–A49T 48
V89L–T187M 59
V89L–F234L 94

Ki: Inhibition constant; WT: Wild-type.

Reproduced with permission from [23].